Skip to search formSkip to main contentSkip to account menu

Taxotere-Platinol-Fluorouracil Regimen

Known as: TPF, DCF, DCF Regimen 
A regimen consisting of docetaxel, cisplatin and fluorouracil used for the treatment of squamous cell head and neck cancer and gastric cancer.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Background: Head and neck squamous cell carcinoma (HNSCC), is a common malignancy in the Indian Population. In locally advanced… 
2010
2010
Mode-locking of semiconductor optical amplifier fiber laser (SOAFL) with 50 fs pulses by extracting the clock of an optical non… 
2010
2010
TPS265^ Background: The DeLOS II trial is a German multicenter (25 centers) randomized phase II trial investigating a docetaxel… 
2010
2010
4075 Background: Docetaxel, cisplatin, and 5FU (DCF) has been shown to be an effective regimen for metastatic adenocarcinoma (ADC… 
2008
2008
In this work, we propose a hybrid medium access scheme that can provide a virtually collision-free environment for an… 
2006
2006
Biotech companies face the need for valuation at various stages: fund raising, licence contracts, initial public offerings and… 
2005
2005
We report a strong enhancement of two-photon fluorescence (TPF) excitation in the evanescent field of a double grating waveguide… 
1983
1983
The effect of inhomogeneities on dose near a gamma-ray source has been investigated. Experimental measurements were made with a… 
1982
1982
Adenosine deaminase (ADA) deficiency has been reported in association with severe combined immunodeficiency disease (SCID). The… 
1981
1981
2'-Deoxycoformycin (dCF), a potent inhibitor of adenosine deaminase, has recently undergone Phase I clinical trials and has been…